Close Menu

NEW YORK (GenomeWeb) – T2 Biosystems said after the close of the market yesterday that it has priced its previously announced public offering of 3.5 million shares of common stock at $9.75 a share, giving the sale a value of $34.1 million before costs. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.